CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in number of surgical procedures
3.4.1.2. Growing awareness regarding blood donations.
3.4.1.3. Rise in use of plasma derived albumin in drug development
3.4.2. Restraints
3.4.2.1. Stringent government regulations
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: ALBUMIN MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Human Serum Albumin
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Bovine Serum Albumin
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Recombinant Albumin
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: ALBUMIN MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Therapeutics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Drug Formulation and Vaccines
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Component of Media
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Other
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: ALBUMIN MARKET, BY SALES CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. B2C
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. B2B
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.3.4. B2B Albumin Market by Type
6.3.4.1. Pharmaceutical Applications Albumin Market by Type
6.3.4.2. Non Pharmaceutical Applications Albumin Market by Type
CHAPTER 7: ALBUMIN MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by Sales Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by Sales Channel
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by Sales Channel
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by Sales Channel
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by Sales Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by Sales Channel
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by Sales Channel
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by Sales Channel
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by Sales Channel
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by Sales Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by Sales Channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by Sales Channel
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by Sales Channel
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by Sales Channel
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by Sales Channel
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by Sales Channel
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by Sales Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by Sales Channel
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by Sales Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by Sales Channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by Sales Channel
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by Sales Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by Sales Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Merck KGaA
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Sartorius AG
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Octapharma AG
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Thermo Fisher Scientific Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. Ventria Bioscience Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Grifols, S.A.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. CSL
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. China Biologic Products Holdings, Inc
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Lazuline Bio
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Takeda Pharmaceutical Company Limited
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
| ※参考情報 アルブミンとは、血漿中に存在する主要な蛋白質の一つで、主に肝臓で合成されます。アルブミンは多機能であり、体内でさまざまな役割を果たしています。一般的には、血液中の浸透圧の維持、薬物やホルモンの輸送、栄養素の運搬などに寄与しています。また、アルブミンは体内の水分バランスを調整する重要な因子です。そのため、アルブミンの量や機能の異常は、腎疾患や肝疾患、心不全などの病状に関連しています。 アルブミンには主に二種類があります。一つはヒトアルブミンであり、もう一つは動物由来のアルブミンです。ヒトアルブミンは、臨床で頻繁に使用され、血液製剤の一部として輸血に利用されます。動物由来のアルブミンは、主に牛の血液から抽出され、実験や研究の分野で用いられます。これらのアルブミンは、特定の条件下で血漿と同様の機能を発揮しますが、それぞれの用途に応じた特性があります。 アルブミンの用途は非常に多岐にわたります。医学の領域では、主に重症患者や手術後の回復期における輸液治療として用いられます。アルブミン製剤は、低アルブミン血症の治療、肝硬変やネフローゼ症候群の治療において、体液のバランスを維持し、腫脹や浮腫を軽減するのに役立ちます。また、アルブミンは血液透析や腹膜透析の過程でも重要な役割を果たします。 研究の分野では、アルブミンは生体内での薬物動態においても大切な因子です。そのため、新薬の開発において、アルブミンの結合特性を考慮することが重要です。多くの薬剤はアルブミンと結合することで、体内での半減期を長くしたり、効果を持続させたりします。このため、アルブミンの研究は新しい薬剤の発見や開発に寄与しています。 関連技術としては、アルブミンの抽出・精製技術や、医療用のアルブミン製剤の製造技術があります。これらの技術は、一般的に血漿成分分画技術やクロマトグラフィーを使用して行われます。特に、アルブミンの純度を高めることは、医療用途において非常に重要です。純度の高いアルブミン製剤は、副作用を抑え、患者により安全な治療を提供することができます。 アルブミンの研究は、今後ますます重要になっていくと考えられています。特に、ヒトアルブミンの合成方法や、新しいアルブミン製剤の開発に関する研究が進められており、これにより患者にとってさらなる治療選択肢が提供されることが期待されています。 アルブミンの測定も重要なスキルであり、通常は血液検査によって行われます。アルブミン濃度が正常範囲内にあるかを確認することで、肝機能や腎機能の状態を把握する指標として利用されます。低アルブミン血症の場合、詳細な診断のためにさらなる検査が行われることが多いです。 このように、アルブミンは生体内で多くの重要な役割を果たしており、様々な医学的・研究的な用途があります。今後もアルブミンに関する技術や研究が進展することで、より良い医療が提供されることが期待されます。アルブミンの重要性を理解することは、医療従事者や研究者にとって不可欠な要素となるでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
